YDS-14702-43574
2 vaccinations
9 coded responses
17 check-ins
9 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 760 / TX
- Registered
- 2021-04-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-18
Dose 1 — Moderna
-
2021-04-09
Registered in v-safe
- 2021-04-09
-
2021-04-15
Dose 2 — Moderna
- 2021-04-15
-
2021-04-16
Survey response — days 1–6 daily, dose 2MedDRA: Arthralgia, Injection site discolouration, Mobility decreased, Muscle tightness — Feeling: Fair · Site: Pain · FeverFree text: Where the needle entered there must havebeen bleeding (morev than just a drop or two). Today there is a purple area about the size of a dime around the point where the needle entered. My shoulder has felt sore and tight all day. There are other symptoms that you list here that I feel but I have arthritis and last week I also injured my lower back and have very limited mobility on account of that.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-17
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: FairFree text: The area around the injection point is even more purple and bruised than yesterday.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-18
Survey response — days 1–6 daily, dose 2MedDRA: Injection site discolouration — Feeling: FairFree text: The immediate area around the injection point is still very purple but not sore.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-19
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: GoodFree text: The area around the injection point is still very purple; no pain or itch.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-20
Survey response — days 1–6 daily, dose 2MedDRA: Injection site discolouration — Feeling: GoodFree text: The area around the injection point is still very purple.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-21
Survey response — days 1–6 daily, dose 2MedDRA: Injection site discolouration — Feeling: GoodFree text: The area around the injection point is still very purple.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Survey response — day 7, dose 2MedDRA: Injection site discolouration — Feeling: GoodFree text: The area around the injection point is still very purple.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-05-27
- 2021-07-15
-
2021-10-14
Survey response — 6 months, dose 2MedDRA: Adverse reaction, Impaired work ability, Self-medication, Sinusitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: 6 days ago I started feeling symptoms of an allergy and sinus infection. Two days later it became serious enough that I decided to miss a meeting with others that I weekly attend. I used OTC allergy medication and now feel much better.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-15
Survey response — 12 months, dose 2MedDRA: Bradykinesia, Fatigue, Herpes zoster, Pain, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I started taking Valacyclovir (1 mg) 3 times daily since Wednesday afternoon for a viral infection (shingles). But I feel tired and sore most of the time, probably due to my arthritis. For the last two weeks I've especially felt tired, sore & slow.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-15
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-19
-
2022-04-19
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Moderna | |
| 2 | 2021-04-15 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-15 | Successful 2022-04-19 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Where the needle entered there must havebeen bleeding (morev than just a drop or two). Today there is a purple area about the size of a dime around the point where the needle entered. My shoulder has felt sore and tight all day. There are other symptoms that you list here that I feel but I have arthritis and last week I also injured my lower back and have very limited mobility on account of that.
Systemic reaction (other): The area around the injection point is even more purple and bruised than yesterday.
Systemic reaction (other): The immediate area around the injection point is still very purple but not sore.
Systemic reaction (other): The area around the injection point is still very purple; no pain or itch.
Systemic reaction (other): The area around the injection point is still very purple.
Systemic reaction (other): The area around the injection point is still very purple.
Release 7 — day 7, dose 2
Systemic reaction (other): The area around the injection point is still very purple.
Release 10 — 6 months, dose 2
Symptoms: 6 days ago I started feeling symptoms of an allergy and sinus infection. Two days later it became serious enough that I decided to miss a meeting with others that I weekly attend. I used OTC allergy medication and now feel much better.
Release 11 — 12 months, dose 2
Symptoms: I started taking Valacyclovir (1 mg) 3 times daily since Wednesday afternoon for a viral infection (shingles). But I feel tired and sore most of the time, probably due to my arthritis. For the last two weeks I've especially felt tired, sore & slow. cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Adverse reaction | · | · | ✓ |
| SD | Bradykinesia | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Herpes zoster | · | · | ✓ |
| SD | Impaired work ability | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Self-medication | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Injection site discolouration | ✓ | ✓ | ✓ |
| SRO | Mobility decreased | ✓ | ✓ | ✓ |
| SRO | Muscle tightness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release